There are several strategies life sciences companies can use to benefit from biosimilars.
Sonia T. Oskouei
Advertisement
Articles by Sonia T. Oskouei
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Patent Term Extension: Challenges with Defining and Claiming Approved Biologics
2
Novo Nordisk Invests $506 Million in Ireland Manufacturing Facility Expansion
3
Pharmaceutical Executive Daily: Novo Nordisk Commits $506 Million to Ireland Manufacturing Site
4
FDA Approves New Indication of Palynziq for Patients 12 Years and Older with Phenylketonuria
5